Literature DB >> 4034458

Pyoderma gangrenosum in myelodysplasia and acute leukaemia.

P Jacobs, S Palmer, E C Gordon-Smith.   

Abstract

Pyoderma gangrenosum is a rare occurrence in patients with haematological malignancy. This characteristic but nonspecific inflammatory process with skin destruction occurred in 4 patients with myelodysplasia, in one with acute leukaemic transformation of myelofibrosis, and in de novo acute myeloblastic leukaemia in another. Clinically, the cutaneous lesion in these patients differed from that associated with inflammatory bowel disease, arthritis, or the idiopathic type of pyoderma gangrenosum by having the vesiculo-bullous borders. Histopathological differences were also evident since more superficial layers of the skin were involved in the ulceration than typically encountered in patients with non-malignant systemic disease. Despite the less penetrating nature of this variant, treatment of the pyoderma gangrenosum is unsatisfactory and in the absence of effective therapy for the underlying disease, healing occurred only in the patient with acute leukaemia who achieved complete remission in response to chemotherapy.

Entities:  

Mesh:

Year:  1985        PMID: 4034458      PMCID: PMC2418352          DOI: 10.1136/pgmj.61.718.689

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  14 in total

1.  Pyoderma gangrenosum; a clinical study of nineteen cases.

Authors:  H O PERRY; L A BRUNSTING
Journal:  AMA Arch Derm       Date:  1957-03

2.  Pyoderma gangrenosum treated with 6-mercaptopurine and followed by acute leukemia.

Authors:  N Maldonado; V M Torres; D Méndez-Cashion; E Pérez-Santiago; M Cáceres de Costas
Journal:  J Pediatr       Date:  1968-03       Impact factor: 4.406

3.  Pyoderma gangrenosum with chronic myeloid leukaemia.

Authors:  D Goldin
Journal:  Proc R Soc Med       Date:  1974-12

4.  Bullous pyoderma gangrenosum and leukemia.

Authors:  H O Perry; R K Winkelmann
Journal:  Arch Dermatol       Date:  1972-12

5.  Letter: Pyoderma gangrenosum and leukemia.

Authors:  C H Tay
Journal:  Arch Dermatol       Date:  1973-10

6.  Pyoderma gangrenosum with response to cyclophosphamide therapy.

Authors:  S E Crawford; R Sherman; B Favara
Journal:  J Pediatr       Date:  1967-08       Impact factor: 4.406

7.  Clofazimine in the treatment of pyoderma gangrenosum.

Authors:  K Thomsen; H W Rothenborg
Journal:  Arch Dermatol       Date:  1979-07

8.  [Pyoderma gangrenosum, ovarian carcinoma treated with Melphalan and acute myelomonocytic leukaemia: report of one case and literature review (author's transl)].

Authors:  J P Ortonne; J Thivolet; B Chouvet; J Coiffet
Journal:  Ann Dermatol Venereol       Date:  1979-03       Impact factor: 0.777

9.  Pyoderma Gangrenosum and rheumatoid arthritis.

Authors:  L P Stolman; D Rosenthal; R Yaworsky; F Horan
Journal:  Arch Dermatol       Date:  1975-08

10.  Pyoderma gangrenosum: clinical and laboratory findings in 15 patients with special reference to polyarthritis.

Authors:  P J Holt; M G Davies; K C Saunders; G Nuki
Journal:  Medicine (Baltimore)       Date:  1980-03       Impact factor: 1.889

View more
  6 in total

1.  Pyoderma gangrenosum: a rare cause of breast ulceration.

Authors:  Georgina Duke; Ahmad Al Samaraee; Akhtar Husain; Simon Meggitt; Tarannum Fasih
Journal:  Ochsner J       Date:  2012

2.  Pyoderma gangrenosum associated with erythroid hypoplasia.

Authors:  C K Wong; K K Pun; C C Lum; S W Lee; M M Ng; C C Wang
Journal:  Postgrad Med J       Date:  1990-04       Impact factor: 2.401

3.  [Management of pyoderma gangrenosum. An update on clinical features, diagnosis and therapy].

Authors:  L Trémezaygues; R Schmaltz; T Vogt; J Reichrath
Journal:  Hautarzt       Date:  2010-04       Impact factor: 0.751

4.  Azacitidine-induced pyoderma gangrenosum at injection sites in a patient with myelodysplastic syndrome.

Authors:  C Roy; J P Adam; F Morin; É Lemieux-Blanchard; S Doucet; D Friedmann; A Belisle; D Charpentier
Journal:  Curr Oncol       Date:  2018-02-28       Impact factor: 3.677

5.  Bullous Variant of Pyoderma Gangrenosum in a Patient with Acute Myeloid Leukemia.

Authors:  Chang-Il Kwon; Gyeong-Won Lee; Chi-Yeon Kim
Journal:  Ann Dermatol       Date:  2022-05-20       Impact factor: 0.722

6.  Bullous pyoderma gangrenosum associated with pancytopenia of unknown origin.

Authors:  Katarzyna Wolska; Małgorzata Michalska-Jakubus; Joanna Pucuła; Grażyna Chodorowska; Grzegorz Dzida; Jerzy Mosiewicz; Andrzej Prystupa; Monika Podhorecka; Dorota Krasowska
Journal:  Postepy Dermatol Alergol       Date:  2014-09-08       Impact factor: 1.837

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.